American Century Companies’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-413,203
| Closed | -$17.5M | – | 2974 |
|
2023
Q4 | $17.5M | Buy |
413,203
+105,460
| +34% | +$4.47M | 0.01% | 922 |
|
2023
Q3 | $6.72M | Sell |
307,743
-1,504
| -0.5% | -$32.8K | 0.01% | 1225 |
|
2023
Q2 | $9.83M | Buy |
309,247
+55,246
| +22% | +$1.76M | 0.01% | 1057 |
|
2023
Q1 | $6.18M | Buy |
254,001
+2,677
| +1% | +$65.2K | ﹤0.01% | 1184 |
|
2022
Q4 | $7.93M | Buy |
+251,324
| New | +$7.93M | 0.01% | 1056 |
|